Upcoming Webinars

Novel Technologies That Aid the Detection and Differentiation of Proteinaceous Impurities in Biologic Drug Substances and Drug Product

Presented by Danny Chou, President and Founder at Compassion BioSolution, LLC
30th November 2020


Janssen CM-strategy: A Story of Multiple Platforms From R&D to Commercial

Presented by Jeroen Geens, Engineering Technical Director at Janssen Research & Development and Dr. Robin Meier, Manager Scientific Operations at L.B. Bohle Maschinen + Verfahren GmbH
03rd December 2020


How can you Best Use Network Analytics and Modelling To Support Digital Engineering In Pharma Manufacturing Operations

Presented by Presented by Gareth Alford, Lead Engineer at GSK and Bob Lenich, Director of Life Sciences Business at Emerson
01st February 2021


Continuous Capture and Continuous Recovery – Novel Ideas for Product Recovery from Perfusion Process Using ATF

Presented by Dr. Kerstin Lange, Team Lead Process Technology and Innovation, Advanced Bioprocessing and And Andrew Falconbridge Vice President Process Technology and Innovation, Alvotech
03rd February 2021


Changing the Paradigm: Moving to In-Process Release Testing

Presented by Presented by Scott Weiss, Director, Industrial Microbiology at Johnson & Johnson and Lori Daane, Pharma Microbiology Scientific Director at bioMérieux
05th February 2021


Future Trends To Control Risks From Extractables and Leachables

Presented by Jason Creasey, Managing Director at Maven E&L Ltd
09th February 2021


Operational Excellence in Process Development in Drug Substance Production

Presented by Ken Green, Ph.D, Head of Manufacturing, Science and Technology at Samsung Biologics.
11th February 2021


Improving Efficiency in Upstream Process Development

Presented by Jackie Gonzalez, Senior Upstream Development Engineer at Takeda, Klaus Mauch, CEO at Insilico Biotechnology AG
01st March 2021


Process Development & Manufacturing Technologies for Bio-therapeutics and Vaccines

Presented by Atin Tomar, Co-Founder & CEO at Yapan Bio, Nirav Desai, Co-Founder at Yapan Bio
03rd March 2021


A Data Driven Biopharmaceutical Manufacturing Facility-Plug and Produce -Shaping the Future Together

Presented by Josef Trapl Global Manufacturing & Supply, Head of MSci Innovation at Takeda and Petter Moree, Global Industry Principal at OSIsoft
04th March 2021


Demonstrate how machine learning tools can aid development of formulation, analysis and manufacturing of pharmaceutical drug products

Presented by Erik Skibsted, Principal Scientist PhD, Novo Nordisk Denmark and Rolf Taaning, Development Specialist PhD, Novo Nordisk Denmark
08th March 2021


Manufacturing in the Industry 4.0 era: how to balance innovation with performance while not being disrupted

Presented by Christos Varsakelis PhD, Senior Manager Global Data Analytics & Innovation, GSK Vaccines, Belgium
10th March 2021


Development and Implementation of Intensified Bioprocessing for Biologics Manufacturing

Presented by Hang Zhou, Ph.D., Vice President, Head of Cell Culture Process Development Biologics and Bioprocess Dept. at WuXi Biologics
12th March 2021


Hybrid Models: The Best of Both (Mechanistic & Empirical) Worlds to Accelerate and De-Risk Process Development

Presented by Christian Airiau, PhD, Global Head Data Sciences, Biologics Development at Sanofi and Chris McCready, Lead Data Scientist at Sartorius Stedim Biotech
16th March 2021


ICH Q3E Guidelines and It’s Implications

Presented by Andrew Teasdale, Senior Principal Scientist Impurity management and External Advocacy at AstraZeneca and Dries Cardoen, Team Leader of Study Directors Inhalation/topical/transdermal products at Nelson Laboratories, LLC
22nd March 2021


Microbiological Attributes, Specifications and Risk Assessment of Culture-based Therapeutic Products

Presented by Tony Cundell, PHD. Principal Consultant, Microbiological Consulting, LLC,
24th March 2021


The Common Road to Quality for Single Use Materials

Presented by Trishna Ray-Chaudhuri, PhD, Principal Technical Manager, Genentech- A Member of the Roche Group and Kevin Mullen, Sr. Product Manager, Single-Use Systems at Thermo Fisher Scientific
21st April 2021


Risk Assessment of Extractables and Leachables in Different Phases of Development.

Presented by Dr Clemens Günther, Senior Expert Nonclinical Safety, Director at Bayer AG, R&D Pharmaceuticals
22nd April 2021


Mycoplasma Testing: Past, Current, and Future State

Presented by Kenneth Tai, Quality Control Scientist, Global Analytical Science Technology at Genentech
29th April 2021


Latest Analytical Techniques in Extractable and Leachables

Presented by Dr. Tom van Wijk, Abbott Healthcare Products BV, Weesp, Principal Scientist, Analytical Science and Technology Team lead Pharmaceutical analysis
20th May 2021